Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Operating Margin (2017 - 2025)

Historic Operating Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 13.74%.

  • Organogenesis Holdings' Operating Margin rose 83200.0% to 13.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.8%, marking a year-over-year increase of 10100.0%. This contributed to the annual value of 0.27% for FY2024, which is 31600.0% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Operating Margin of 13.74% as of Q3 2025, which was up 83200.0% from 12.45% recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Operating Margin peaked at 19.15% during Q2 2021, and registered a low of 30.85% during Q1 2025.
  • Over the past 5 years, Organogenesis Holdings' median Operating Margin value was 7.42% (recorded in 2023), while the average stood at 3.18%.
  • As far as peak fluctuations go, Organogenesis Holdings' Operating Margin surged by 367400bps in 2021, and later tumbled by -273500bps in 2025.
  • Organogenesis Holdings' Operating Margin (Quarter) stood at 15.45% in 2021, then plummeted by -51bps to 7.55% in 2022, then crashed by -117bps to 1.27% in 2023, then soared by 734bps to 8.07% in 2024, then soared by 70bps to 13.74% in 2025.
  • Its Operating Margin was 13.74% in Q3 2025, compared to 12.45% in Q2 2025 and 30.85% in Q1 2025.